Self-emulsifying formulations of DIM-related indoles

Inventors

Zeligs, Michael A. • Jacobs, Irwin C.

Assignees

BioResponse LLC

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-10441569-B2

Patent

Publication Date

2019-10-15

Expiration Date


Abstract

Disclosed herein are self-emulsifying compositions and formulations of Diindolylmethane (“DIM”) and certain derivatives of DIM, their uses and methods of making. In particular, the disclosed compositions comprise a DIM-related indole as an active agent and a carrier, wherein the carrier comprises a solvent, one or more surfactants with an HLB of greater than 7, and one or more co-surfactants with an HLB equal to or less than 7. In certain aspects of the invention, the compositions disclosed herein show improved bioavailability.

Core Innovation

The composition comprises 3,3′-diindolylmethane (DIM) as the biologically active agent and a carrier comprising an essential oil, lauroyl polyoxyl-32 glyceride, propylene glycol caprylate, polysorbate 80 or tocopherol PEG 1000 succinate, and lecithin. Disclosed formulations also encompass DIM-related indoles, peppermint oil, phosphatidylcholine, and optional additional active ingredients. Upon dispersion in water or contact with gastrointestinal fluids, the composition emulsifies to form a dispersion of oil-in-water globules.

The formulation keeps the active compound dissolved and limits recrystallization during processing and storage. Stated formulation outcomes include increased DIM loading, reduced globule size, limited recrystallization, and controlled room-temperature storage stability. Additionally, self-microemulsifying formulations demonstrate improved oral bioavailability and higher DIM exposure compared to crystalline or spray-dried DIM formulations.

Claims Coverage

The claims identify one independent claim, claim 1, comprising two inventive features directed to a DIM composition and its emulsion formation.

DIM composition with a specified carrier

Claim 1 covers a composition comprising 3,3′-diindolylmethane (DIM) as the biologically active agent and a carrier comprising an essential oil selected from peppermint oil, tea tree oil, wintergreen oil, lemon oil, lime oil, lavender oil, ginger oil, nutmeg oil, fennel oil, eucalyptus oil, rosemary oil, pomegranate seed oil, black cumin oil, clove oil, mustard oil, or cinnamon bark oil; lauroyl polyoxyl-32 glyceride; propylene glycol caprylate; polysorbate 80 or tocopherol PEG 1000 succinate; and lecithin.

Formation of oil-in-water globules

Upon dispersion in water or contact with gastrointestinal fluids, the composition emulsifies to form a dispersion of oil-in-water globules.

The independent claim defines the DIM composition by its specified carrier components and its emulsification into oil-in-water globules in water or gastrointestinal fluids, while dependent claims further define ingredients and treatment methods.

Stated Advantages

The formulation increases DIM loading.

The formulation, including disclosed phosphatidylcholine and Poloxamer 124, reduces globule size and limits recrystallization of the active compound.

The formulation improves oral bioavailability, with SMEDDS formulations providing higher DIM exposure than crystalline or spray-dried DIM.

Storage data indicate that DIM remains in formulation during controlled room-temperature storage over three months.

Documented Applications

The formulations are described for oral, topical, nutritional, and veterinary applications.

The composition is described for applications involving methods of treating acne or atopic dermatitis.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.